- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 6, 2026 | 12.87M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 13.54M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 13.65M sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 13.14M sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 13.14M sh |
| Dividends Paid | Q3 2026 · Mar 31, 2026 | $4.98M |
| Dividends Paid | Q3 2026 · Mar 31, 2025 | $4.59M |
| Capex | Q3 2026 · Mar 31, 2026 | $5.27M |
| Capex | Q3 2026 · Mar 31, 2025 | $3.16M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | $7.25M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | $11.33M |
| Long Term Debt | Q3 2026 · Mar 31, 2026 | $60M |
| Long Term Debt | Q3 2026 · Jun 30, 2025 | $53M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $146M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $143.97M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $143.48M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $140.21M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $138.01M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $136.61M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $95.47M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $94.86M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $172.23M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $163.55M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $153.19M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $145.44M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $318.23M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $307.03M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.05 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.31 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $0.07 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $0.35 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.05 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.33 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $0.07 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $0.36 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $30.56M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $92.17M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $25.78M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $74.78M |
| Net Income | Q3 2026 · Mar 31, 2026 | $753K |
| Net Income | Q3 2026 · Mar 31, 2026 | $4.97M |
| Net Income | Q3 2026 · Mar 31, 2025 | $1.04M |
| Net Income | Q3 2026 · Mar 31, 2025 | $5.4M |
| Operating Income | Q3 2026 · Mar 31, 2026 | $2.26M |
| Operating Income | Q3 2026 · Mar 31, 2026 | $10.07M |
| Operating Income | Q3 2026 · Mar 31, 2025 | $2.28M |
| Operating Income | Q3 2026 · Mar 31, 2025 | $9.65M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $32.82M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $102.24M |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $28.06M |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $84.43M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $68.31M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $222.45M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $65.48M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $195.44M |